News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
231,164 Results
Type
Article (10675)
Company Profile (46)
Press Release (220443)
Multimedia
Podcasts (7)
Webinars (5)
Section
Business (58957)
Career Advice (451)
Deals (10376)
Drug Delivery (29)
Drug Development (25679)
Employer Resources (43)
FDA (7009)
Job Trends (5125)
News (104355)
Policy (10403)
Tag
2027 Pharm Country Standard (1)
Academia (947)
Accelerated approval (16)
Adcomms (10)
Allergies (37)
Alliances (18539)
ALS (70)
Alzheimer's disease (544)
Antibody-drug conjugate (ADC) (124)
Approvals (7173)
Artificial intelligence (275)
Autoimmune disease (46)
Automation (21)
Bankruptcy (76)
Best Places to Work (4674)
BIOSECURE Act (3)
Biosimilars (53)
Biotechnology (27)
Bladder cancer (108)
Brain cancer (46)
Breast cancer (378)
Cancer (2661)
Cardiovascular disease (167)
Career advice (399)
Career pathing (5)
CAR-T (101)
CDC (12)
Celiac Disease (1)
Cell therapy (253)
Cervical cancer (21)
Clinical research (23398)
Collaboration (711)
Compensation (160)
Complete response letters (13)
COVID-19 (1011)
CRISPR (36)
C-suite (248)
Cystic fibrosis (49)
Data (2813)
Decentralized trials (1)
Denatured (3)
Depression (46)
Diabetes (183)
Diagnostics (6407)
Digital health (26)
Diversity (3)
Diversity, equity & inclusion (12)
Drug discovery (76)
Drug pricing (24)
Drug shortages (4)
Duchenne muscular dystrophy (62)
Earnings (23679)
Editorial (12)
Employer branding (5)
Employer resources (41)
Events (31216)
Executive appointments (316)
FDA (8422)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (3)
Funding (549)
Gene editing (61)
Generative AI (22)
Gene therapy (158)
GLP-1 (252)
Government (1427)
Grass and pollen (1)
Guidances (181)
Healthcare (7073)
HIV (20)
Huntington's disease (6)
IgA nephropathy (34)
Immunology and inflammation (57)
Immuno-oncology (28)
Indications (36)
Infectious disease (1110)
Inflammatory bowel disease (54)
Inflation Reduction Act (2)
Influenza (52)
Intellectual property (68)
Interviews (74)
IPO (4543)
IRA (6)
Job creations (662)
Job search strategy (328)
JPM (15)
Kidney cancer (9)
Labor market (9)
Layoffs (68)
Leadership (7)
Legal (1395)
Liver cancer (48)
Longevity (4)
Lung cancer (370)
Lymphoma (213)
Machine learning (18)
Management (17)
Manufacturing (302)
MASH (39)
Medical device (5881)
Medtech (5909)
Mergers & acquisitions (6322)
Metabolic disorders (362)
Multiple sclerosis (60)
NASH (7)
Neurodegenerative disease (107)
Neuropsychiatric disorders (29)
Neuroscience (948)
Neurotech (1)
NextGen: Class of 2026 (1871)
Non-profit (1434)
Now hiring (3)
Obesity (129)
Opinion (100)
Ovarian cancer (93)
Pain (47)
Pancreatic cancer (121)
Parkinson's disease (80)
Partnered (16)
Patents (137)
Patient recruitment (214)
Peanut (9)
People (15913)
Pharmaceutical (10)
Pharmacy benefit managers (4)
Phase 1 (6597)
Phase 2 (10096)
Phase 3 (8764)
Pipeline (2211)
Policy (47)
Postmarket research (813)
Preclinical (2127)
Press Release (17)
Prostate cancer (146)
Psychedelics (14)
Radiopharmaceuticals (171)
Rare diseases (253)
Real estate (1716)
Recruiting (18)
Regulatory (9406)
Reports (16)
Research institute (982)
Resumes & cover letters (68)
Rett syndrome (8)
RNA editing (1)
RSV (12)
Schizophrenia (49)
Series A (95)
Series B (66)
Service/supplier (2)
Sickle cell disease (22)
Special edition (4)
Spinal muscular atrophy (36)
Sponsored (23)
Startups (1053)
State (2)
Stomach cancer (6)
Supply chain (29)
Tariffs (5)
The Weekly (4)
Vaccines (255)
Venture capital (28)
Weight loss (77)
Women's health (41)
Worklife (1)
Date
Today (4)
Last 7 days (229)
Last 30 days (875)
Last 365 days (11427)
2026 (1078)
2025 (11667)
2024 (13381)
2023 (14694)
2022 (19443)
2021 (19676)
2020 (18890)
2019 (15674)
2018 (12019)
2017 (11286)
2016 (10726)
2015 (12322)
2014 (8739)
2013 (7489)
2012 (8064)
2011 (8406)
2010 (7287)
Location
Africa (250)
Alabama (35)
Alaska (3)
Arizona (125)
Arkansas (3)
Asia (13670)
Australia (2606)
California (4158)
Canada (1133)
China (425)
Colorado (244)
Connecticut (175)
Delaware (163)
Europe (33040)
Florida (623)
Georgia (109)
Idaho (17)
Illinois (372)
India (27)
Indiana (177)
Iowa (8)
Japan (185)
Kansas (55)
Kentucky (20)
Louisiana (9)
Maine (33)
Maryland (409)
Massachusetts (2637)
Michigan (125)
Minnesota (231)
Mississippi (2)
Missouri (65)
Montana (11)
Nebraska (12)
Nevada (29)
New Hampshire (50)
New Jersey (1284)
New Mexico (18)
New York (1151)
North Carolina (568)
North Dakota (9)
Northern California (2082)
Ohio (115)
Oklahoma (10)
Oregon (16)
Pennsylvania (639)
Puerto Rico (5)
Rhode Island (17)
South America (333)
South Carolina (17)
Southern California (1568)
Tennessee (86)
Texas (671)
United States (14783)
Utah (226)
Vermont (1)
Virginia (114)
Washington D.C. (32)
Washington State (320)
West Virginia (2)
Wisconsin (75)
Wyoming (2)
231,164 Results for "gold standard diagnostics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
OCEAN Dx Rapid Diagnostic Test for Sepsis Matched Gold Standard During a Clinical Evaluation Study
November 18, 2025
·
2 min read
FDA
FDA Expert Panels Lack Balance in Pursuit of ‘Gold Standard Science’
New FDA expert panels, such as recent meetings on SSRI use during pregnancy and on hormone replacement therapy during menopause, are drawing criticism for being one-sided. One leader says such panels are designed to reach a specific conclusion.
September 8, 2025
·
6 min read
·
Ben Hargreaves
Press Releases
Telomir Pharmaceuticals Reports Telomir-1 Outperforms FDA-Approved Gold-Standard Iron Chelator Deferoxamine (DFO) in Reducing Intracellular Iron in a Human Cell Line
November 13, 2025
·
6 min read
Insights
The New Gold Rush in Brain Science
Fueled by advances in biomarkers, brain mapping, and AI, investment in neuro and CNS innovation shows no signs of slowing, even amid costly setbacks.
BioSpace
spoke to investors at JPM26 to get their take on recent bets in new therapies and neurotech.
January 22, 2026
·
5 min read
·
Jennifer Smith-Parker
Press Releases
Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator (DxA) Partners with Siemens Healthineers to License DxA’s SpeechDx Dataset, Gold-Standard Dataset for Alzheimer’s Speech Biomarkers
May 1, 2025
·
6 min read
Press Releases
Standard BioTools Completes Sale of SomaLogic to Illumina
February 1, 2026
·
6 min read
Press Releases
ENDRA’s Ongoing Multisite Pilot Study Reveals Important Enhancements to Boost TAEUS Liver Accuracy and Repeatability Against MRI Gold Standard
June 17, 2025
·
5 min read
Press Releases
BioMark Diagnostics Advances Commercialization Strategy by Initiating ISO 15189 Accreditation Program
Company engages Standards Council of Canada; targets ISO 15189 accreditation for early 2026
December 23, 2025
·
3 min read
Press Releases
Catalight Chief Clinical Officer Dr. Doreen Samelson Named Gold Winner in 2025 Merit Awards for Healthcare
December 5, 2025
·
3 min read
Press Releases
IPA’s LENSai™ Platform Delivers X-Ray–Level Epitope Mapping Insights in Hours, Matching Gold-Standard Methods with Greater Speed
May 12, 2025
·
5 min read
1 of 23,117
Next
